A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Nai-Jen Hou, Li-Po Lee, Ming-Yen Hsieh, Chang-Fu Chiu, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Wan-Long Chuang
Gut Apr 2007, 56 (4) 553-559; DOI: 10.1136/gut.2006.102558
